Neuropace Inc. Common Stock (NPCE)

About NPCE

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable ac…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

220

Website

www.neuropace.com/

Fundamentals

1-day range

$14.45$15.28

Market cap

$473.90M

P/E (trailing)

—

P/E (forward)

-65.89

EPS (trailing)

$-0.65

Dividend yield

—

Beta

1.88

Avg. volume

190.8K

Forecasts

9 analyst ratings

Neuropace Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NPCE

  Neuropace Inc. Common Stock

  $14.41

  ▲ 1.98%
  Market cap $473.90MP/E —
  $8.76$19.6
• CERS

  Cerus Corporation Common Stock

  $2.65

  ▼ 2.57%
  Market cap $467.54MP/E —
  $1.17$3.47
• MOBI

  Mobia Medical Inc. Common Stock

  $11.37

  ▲ 7.22%
  Market cap $409.63MP/E —
  $10.19$15.29
• SGHT

  Sight Sciences Inc. Common Stock

  $8.54

  ▲ 1.55%
  Market cap $385.77MP/E —
  $3.19$9.24
• MDXG

  MiMedx Group Inc Common Stock

  $4.49

  ▼ 0.44%
  Market cap $609.28MP/E 98.12
  $3.03$7.97
• BWAY

  BrainsWay Ltd. American Depositary Shares

  $14.29

  ▼ 0.76%
  Market cap $626.52MP/E 72.19
  $2,391$5,123
• TCMD

  Tactile Systems Technology Inc. Common Stock

  $23.15

  ▲ 0.17%
  Market cap $650.97MP/E 26.91
  $12.91$37.77

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• NeuroPace Inc (NPCE) (Q2 2026) Earnings Call Highlights: Strong RNS Growth and AI Launch Offset ...
  Yahoo · 8/19/2026
• NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
  Yahoo · 8/17/2026
• Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
  Yahoo · 8/17/2026
• NPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity?
  Yahoo · 8/17/2026
• NeuroPace, Inc. (NPCE) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/14/2026
• NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up
  Yahoo · 8/12/2026
• NeuroPace, Inc. Q2 2026 Earnings Call Summary
  Yahoo · 8/12/2026
• NeuroPace Q2 Earnings Call Highlights
  Yahoo · 8/12/2026

• Martha Morrell · August 27, 2026 · Tax Withholding

  358 @ $14.13
• Joel Becker · August 27, 2026 · Tax Withholding

  1.1K @ $14.13
• Martha Morrell · June 24, 2026 · Tax Withholding

  335 @ $16.22
• Rakhi Kumar · June 19, 2026 · Grant

  989 @ $15.63
• Uri Geiger · June 19, 2026 · Grant

  789 @ $15.63
• Frank M. Fischer · June 19, 2026 · Grant

  1.5K @ $15.63
• Rakhi Kumar · June 5, 2026 · Grant

  5.4K
• Rakhi Kumar · June 5, 2026 · Grant

  2.9K
• Renee Ryan · June 5, 2026 · Grant

  5.4K
• Renee Ryan · June 5, 2026 · Grant

  2.9K
• Lisa Andrade · June 5, 2026 · Grant

  5.4K
• Lisa Andrade · June 5, 2026 · Grant

  2.9K
• Uri Geiger · June 5, 2026 · Grant

  5.4K
• Uri Geiger · June 5, 2026 · Grant

  2.9K
• R. Scott Huennekens · June 5, 2026 · Grant

  5.4K

Institutional Ownership

March 31, 2026

Total shares held

25.95M

Total value held

$336.97M

Institutional holders

108